Zepp Health [ZEPP] vs Vuzix [VUZI] Detailed Stock Comparison
Zepp Health
NYSE
Loading...
Vuzix
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Zepp Health wins in 16 metrics, Vuzix wins in 2 metrics, with 0 ties. Zepp Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zepp Health | Vuzix | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.31 | -2.09 | Zepp Health |
| Price-to-Book Ratio | 1.57 | 4.62 | Zepp Health |
| Debt-to-Equity Ratio | 47.49 | 1.09 | Vuzix |
| PEG Ratio | -2,239.00 | -4.74 | Zepp Health |
| EV/EBITDA | -105.68 | -3.50 | Zepp Health |
| Profit Margin (TTM) | -38.81% | -97.31% | Zepp Health |
| Operating Margin (TTM) | -10.27% | -556.18% | Zepp Health |
| Return on Equity | -28.32% | -136.11% | Zepp Health |
| Return on Assets (TTM) | -5.10% | -46.89% | Zepp Health |
| Free Cash Flow (TTM) | $-25.88M | $-26.66M | Zepp Health |
| 1-Year Return | 849.22% | 119.23% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 1.61 | 28.46 | Zepp Health |
| Enterprise Value | $4.47B | $136.85M | Zepp Health |
| EV/Revenue Ratio | 22.34 | 25.67 | Zepp Health |
| Gross Profit Margin (TTM) | 37.27% | -16.77% | Zepp Health |
| Revenue per Share (TTM) | $12 | $0 | Zepp Health |
| Earnings per Share (Diluted) | $-4.80 | $-1.03 | Vuzix |
| Beta (Stock Volatility) | 1.12 | 1.40 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zepp Health vs Vuzix Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zepp Health | 2.26% | 80.53% | 598.28% | 860.47% | 740.83% | 746.69% |
| Vuzix | -1.67% | 4.48% | -19.85% | 20.00% | -47.76% | -49.28% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zepp Health | 849.22% | 197.79% | -58.39% | -46.62% | -46.62% | -46.62% |
| Vuzix | 119.23% | -77.63% | -35.04% | -44.53% | -72.36% | -82.12% |
Performance & Financial Health Analysis: Zepp Health vs Vuzix
| Metric | ZEPP | VUZI |
|---|---|---|
| Market Information | ||
| Market Cap | $321.70M | $151.72M |
| Market Cap Category | Small cap | Micro cap |
| 10 Day Avg. Volume | 333,011 | 1,228,780 |
| 90 Day Avg. Volume | 1,044,594 | 1,700,267 |
| Last Close | $24.85 | $2.07 |
| 52 Week Range | $2.12 - $27.86 | $0.83 - $5.79 |
| % from 52W High | -10.80% | -64.34% |
| All-Time High | $81.00 (Feb 15, 2021) | $32.43 (Apr 05, 2021) |
| % from All-Time High | -69.32% | -93.62% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | -0.21% |
| Quarterly Earnings Growth | 5.89% | -0.21% |
| Financial Health | ||
| Profit Margin (TTM) | -0.39% | -0.97% |
| Operating Margin (TTM) | -0.10% | -5.56% |
| Return on Equity (TTM) | -0.28% | -1.36% |
| Debt to Equity (MRQ) | 47.49 | 1.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.22 | $0.43 |
| Cash per Share (MRQ) | $0.22 | $0.20 |
| Operating Cash Flow (TTM) | $-25,970,000 | $-18,387,856 |
| Levered Free Cash Flow (TTM) | $-134,703,985 | $-4,699,632 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Zepp Health vs Vuzix
| Metric | ZEPP | VUZI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.31 | -2.09 |
| Forward P/E | -2,239.00 | -4.74 |
| PEG Ratio | -2,239.00 | -4.74 |
| Price to Sales (TTM) | 1.61 | 28.46 |
| Price to Book (MRQ) | 1.57 | 4.62 |
| Market Capitalization | ||
| Market Capitalization | $321.70M | $151.72M |
| Enterprise Value | $4.47B | $136.85M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.34 | 25.67 |
| Enterprise to EBITDA | -105.68 | -3.50 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 1.40 |
| Book Value per Share (MRQ) | $14.22 | $0.43 |
Financial Statements Comparison: Zepp Health vs Vuzix
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZEPP | VUZI |
|---|---|---|
| Revenue/Sales | $38.54M | $1.58M |
| Cost of Goods Sold | $24.18M | $1.85M |
| Gross Profit | $14.36M | $-265,118 |
| Research & Development | $12.38M | $2.61M |
| Operating Income (EBIT) | $-18.38M | $-8.79M |
| EBITDA | $-17.79M | $-8.32M |
| Pre-Tax Income | $-19.27M | $-8.64M |
| Income Tax | $110,000 | $0 |
| Net Income (Profit) | $-19.74M | $-8.64M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZEPP | VUZI |
|---|---|---|
| Cash & Equivalents | $76.43M | $15.23M |
| Total Current Assets | $242.46M | $22.39M |
| Total Current Liabilities | $212.34M | $2.92M |
| Long-Term Debt | $71.16M | N/A |
| Total Shareholders Equity | $232.04M | $32.85M |
| Retained Earnings | $8.88M | $-376.16M |
| Property, Plant & Equipment | $9.56M | $9.89M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZEPP | VUZI |
|---|---|---|
| Operating Cash Flow | $-14.63M | $-3.03M |
| Capital Expenditures | $-2.92M | $-613,397 |
| Free Cash Flow | $-16.89M | $-4.17M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ZEPP | VUZI |
|---|---|---|
| Shares Short | 308,546 | 18.23M |
| Short Ratio | 0.25 | 9.82 |
| Short % of Float | 0.05% | 0.26% |
| Average Daily Volume (10 Day) | 333,011 | 1,228,780 |
| Average Daily Volume (90 Day) | 1,044,594 | 1,700,267 |
| Shares Outstanding | 231.98M | 75.97M |
| Float Shares | 108.71M | 63.75M |
| % Held by Insiders | 0.06% | 0.17% |
| % Held by Institutions | 0.26% | 0.22% |
Dividend Analysis & Yield Comparison: Zepp Health vs Vuzix
| Metric | ZEPP | VUZI |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |